摘要
目的评价目前高效抗逆转录病毒治疗(HAART)方案的疗效,为以后的治疗方案提供参考。方法应用国家免费提供的抗病毒治疗药品,对符合治疗条件的艾滋病病毒(HIV)感染者/艾滋病(AIDS)病例进行规范的抗病毒治疗,并检测病例的病毒载量和淋巴细胞。结果治疗1~12个月,治疗病例CD4+T淋巴细胞计数呈明显上升趋势,均值为266.2;12个月之后,CD4+T淋巴细胞计数相对稳定,均值为353.1。治疗12个月前后,其差异具有统计学意义(P<0.05)。治疗1~7个月,病例病毒载量计数呈明显下降趋势;治疗7个月之后,病例病毒载量计数相对变化较为稳定。治疗7个月前后,其差异有显著的统计学意义(P<0.01)。结论浙江省艾滋病例在接受抗病毒治疗1年后,治疗效果明显,病例状态持续稳定。
Objective To evaluate the curative effect of highly active antiretroviral therapy (HA.ART) and provide scientific evidence for the further use. Methods Each individual with HIV/AIDS was offered standardized anfiretreviral drugs free of charge by government. Then HIV viral loads and CD^4+ T of each subject were detected periodically. Result During the first 12 months of HAART, the level of CD^4+ T in AIDS eases increased markedly and was 266.2. After 12 months, the level of CD^4+ T kept steady with an average level of 353. 1. There was signifioant difference of CD^4+ T levels before and after 12 months ( P〈0.05 ). Additionally, during the first 7 months of HAART, the viral load decreased markedly and was 2.271g copies/ml. After 7 months, the viral load kept steady with an average level of 1.72 lg eopies./ml. Similarily, there was significant difference of viral load before and after 7 months ( P〈 0.01 ). Conclusion After one year treatment, the curative effect of HARRT is obvious and the effectiveness remains steady.
出处
《浙江预防医学》
2010年第1期5-7,共3页
Zhejiang Journal of Preventive Medicine
关键词
艾滋病
高效抗逆转录病毒治疗
效果
临床评价
HIV/AIDS
Highly active antiretroviral therapy (HAART)
Effectiveness
Clinical evaluation